PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis
NCT00567840
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
69
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Tuberculosis
Interventions
DRUG:
PA-824
Sponsor
Global Alliance for TB Drug Development